Evaluation of drug resistance of patients with tuberculosis over a period of thirty years Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003
The risk of tuberculosis disease among HIV infected patients after 2 years of follow up Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007
On investigation of the reproductive function status among women with pulmonary tuberculosis (TB) Source: Eur Respir J 2005; 26: Suppl. 49, 416s Year: 2005
Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario Source: Eur Respir J 2006; 28: Suppl. 50, 858s Year: 2006
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Family planning, pregnancy and birth in women with lung conditions: a worldwide survey Source: ERJ Open Res, 7 (4) 00357-2021; 10.1183/23120541.00357-2021 Year: 2021
Pyrosequencing(PSQ) in early diagnosis of CNS tuberculosis and determining drug resistance. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Particularities of tuberculosis in pregnant women and women during of the first 3 years after childbirth Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Neonatal antibiotic treatment increases the risk of asthma at age 12 years Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients Source: Eur Respir J 2001; 18: 306-315 Year: 2001
How to protect children from the risk of tuberculosis disease? The contact study. Management suggestions based on a 11 year experience Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals? Source: Eur Respir J 2005; 25: 751-757 Year: 2005
Using results of drug sensitivity of infection source in initial chemotherapy choice in TB children and teenagers Source: Eur Respir J 2006; 28: Suppl. 50, 12s Year: 2006
Primary and acquired drug resistance in childhood tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 653s Year: 2005
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
The experience of directly observed therapy in Esrefpasa tuberculosis dispensary for two years Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005